(Q38646657)

5 September 2017

Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results (English)

1 reference

5 September 2017

Felix Bokstein

1

1 reference

5 September 2017

Deborah T Blumenthal

2

1 reference

5 September 2017

Benjamin W Corn

3

1 reference

5 September 2017

Eliahu Gez

4

1 reference

5 September 2017

Diana Matceyevsky

5

1 reference

5 September 2017

Natan Shtraus

6

1 reference

5 September 2017

Zvi Ram

7

1 reference

5 September 2017

Andrew A Kanner

8

1 reference

5 September 2017

24 November 2015

1 reference

Journal of Neuro-Oncology

5 September 2017

1 reference

5 September 2017

126

1 reference

5 September 2017

3

1 reference

5 September 2017

551-557

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-015-1997-5

5 September 2017

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Hypofractionated stereotactic reirradiation for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Salvage radiosurgery for selected patients with recurrent malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Radiation therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

γ knife surgery versus reoperation for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Stereotactic radiosurgery for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Irradiation and bevacizumab in high-grade glioma retreatment settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1997-5

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26603164

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-015-1997-5

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference